Skip to main content
Log in

Increased production of nitric oxide in patients with hemorrhagic fever with renal syndrome — Relation to arterial hypotension and tumor necrosis factor

Erhöhte Bildung von Stickoxiden bei Patienten mit hämorrhagischem Fieber und renalem Syndrom. Beziehung zu arterieller Hypotonie und Tumornekrosefaktor

  • Originalia
  • Published:
Infection Aims and scope Submit manuscript

Summary

In 15 consecutive subjects hospitalized with nephropathia epidemica, a European form of hemorrhagic fever with renal syndrome, the plasma concentrations of nitrate plus nitrite, stable metabolites of nitric oxide, were determined. From day 3 of onset of disease the concentrations increased, peak levels being reached on days 5 to 7. Maximal plasma concentrations of nitrate plus nitrite were correlated to the degree of hypotension (r=−0.64, p=0.02) and levels of tumor necrosis factor (TNF)-α (r=0.51, p=0.05) and soluble TNF receptors p55 and p75 (r=0.58, p=0.03 and r=0.54, p=0.04, respectively) but not to levels of interferon-γ or interleukin-10 (p>0.05). The results are compatible with the well-known capacity of TNF-α to enhance production of nitric oxide, and suggest that nitric oxide may be of physiologic importance in hemorrhagic fever with renal syndrome.

Zusammenfassung

Bei 15 aufeinanderfolgenden, stationär eingewiesenen Patienten mit Nephropathia epidemica, einer europäischen Form des hämorragischen Fiebers mit renalen Syndrom, wurden die Plasmakonzentrationen von Nitrat plus Nitrit, den stabilen Metaboliten von Stickoxid, gemessen. Von dem dritten Tag nach Ausbruch der Krankheit an begannen die Konzentrationen anzusteigen. Höchstwerte wurden am Tag 5–7 beobachtet. Maximale Plasmakonzentrationen von Nitrat plus Nitrit waren mit dem Grad der Hypotension korreliert (r = −0.64, p = 0.02) und auch mit der Konzentration Tumor-Nekrose-Faktor (TNF)-α (r = 0.51, p = 0.05) und löslichen TNF Rezeptoren p55 und p75 (r = 0.58, p = 0.03 und r = 0.54, p = 0.04), aber nicht mit den Interferon-γ oder Interleukin-10 Werten (p>0.05). Die TNF-α-abhängige Produktion von Stickoxiden könnte von pathophysiologischer Bedeutung bei Nephropathia epidemica sein.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Cosgriff, T. M. Mechanisms of disease in hantavirus infection: pathophysiology of hemorrhagic fever with renal syndrome. Rev. Infect. Dis. 13 (1991) 97–107.

    Google Scholar 

  2. Duchin, J. S., Koster, F. T., Peters, C. J., Simpson, G. L., Tempest, B., Zaki, S. R., Ksiazek, D. V. M., Rollin, P. E., Nichol, S., Umland, E. T., Moolenaar, R. L., Reef, S. E., Nolte, K. B., Gallaher, M. M., Butler, J. C., Breiman, R. F., andthe Hantavirus Study Group Hantavirus pulmonary syndrome: a clinical description of 17 patients with a newly recognized disease. N. Engl. J. Med. 330 (1994) 949–955.

    Google Scholar 

  3. Settergren, B., Juto, P., Trollfors, B., Wadell, G., Norrby, S. R. Clinical characteristics of nephropathia epidemica in Sweden: prospective study of 74 cases. Rev. Infect. Dis. 11 (1989) 921–927.

    Google Scholar 

  4. Linderholm, M., Ahlm, C., Settergren, B., Waage, A., Tärnvik, A. Elevated plasma levels of tumor necrosis factor (TNF)-α, soluble TNF receptors, interleukin (IL)-6, and IL-10 in patients with hemorrhagic fever with renal syndrome. J. Infect. Dis. 173 (1996) 38–43.

    Google Scholar 

  5. Spriggs, D. R., Sherman, M. L., Michie, H., Arthur, K. A., Imamura, K., Wilmore, D., Frei III, E., Kufe, D. W. Recombinant human tumor necrosis factor administered as a 24-hour intravenous infusion. A phase I and pharmacological study. J. Natl. Cancer Inst. 80 (1988) 1039–1044.

    Google Scholar 

  6. Moncada, S. The L-arginine: nitric oxide pathway. Acta Physiol. Scand. 145 (1992) 201–227.

    Google Scholar 

  7. Hibbs, J. B. Jr., Westenfelder, C., Taintor, R., Vavrin, Z., Kablitz, C., Baranowski, R. L., Ward, J. H., Menlove, R. L., McMurry, M. P., Kushner, J. P., Samlowski, W. E. Evidence for cytokine-inducible nitrix oxide synthesis from L-arginine in patients receiving interleukin-2 therapy. J. Clin. Invest. 89 (1992) 867–877.

    Google Scholar 

  8. Groeneveld, P. H. P., Colson, P., Kwappenberg, K. M. C., Clement, J. Increased production of nitrix oxide in patients infected with the European variant of hantavirus. Scand. J. Infect. Dis. 27 (1995) 453–456.

    Google Scholar 

  9. Elgh, F., Wadell, G., Juto, P. Comparison of the kinetics of Puumala virus specific IgM and IgG antibody responses in nephropathia epidemica as measured by a recombinant antigen-based enzyme-linked immunosorbent assay and an immunofluorescent test. J. Med. Virol. 45 (1995) 146–150.

    Google Scholar 

  10. Wagner, D. A., Schultz, D. S., Deen, W. M., Young, V. R., Tannenbaum, S. R. Metabolic fate of an oral dose of15N-labeled nitrate in humans: effect of diet supplementation with ascorbic acid. Canc. Res. 43 (1983) 1921–1925.

    Google Scholar 

  11. Deakin, A. M., Payne, A. N., Whittle, B. J. R., Moncada, S. The modulation of IL-6 and TNF-α release by nitrix oxide following stimulation of J774 cells with LPS and IFN-γ. Cytokine 7 (1995) 408–416.

    Google Scholar 

  12. Evans, T., Carpenter, A., Kinderman, H., Cohen, J. Evidence of increased nitrix oxide production in patients with the sepsis syndrome. Circ. Shock 41 (1993) 77–81.

    Google Scholar 

  13. Ochoa, J. B., Udekwu, A. O., Billiar, T. R., Curran, R. D., Cerra, F. B., Simmons, R. L., Peitzman, A. B. Nitrogen oxide levels in patients after trauma and during sepsis. Ann. Surg. 214 (1991) 621–626.

    Google Scholar 

  14. Reyes, A. A., Martin, D., Settle, S., Klahr, S. EDRF role in renal function and blood pressure of normal rats and rats with obstructive nephropathy. Kidney Int. 41 (1992) 403–413.

    Google Scholar 

  15. Narita, I., Border, W. A., Ketteler, M., Noble, N. A. Nitrix oxide mediates immunological injury to kidney mesangium in experimental glomerulonephritis. Lab. Invest. 72 (1995) 17–24.

    Google Scholar 

  16. Radomski, M. W., Palmer, R. M. J., Moncada, S. The role of nitrix oxide and cGMP in platelet adhesion to vascular endothelium. Biochem. Biophys. Res. Commun, 148 (1987) 1482–1489.

    Google Scholar 

  17. Evans, T., Carpenter, A., Silva, A., Cohen, J. Inhibition of nitric oxide synthase in experimental gram-negative sepsis. J. Infect. Dis. 169 (1994) 343–349.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Linderholm, M., Tärnvik, A. & Groeneveld, P.H.P. Increased production of nitric oxide in patients with hemorrhagic fever with renal syndrome — Relation to arterial hypotension and tumor necrosis factor. Infection 24, 337–340 (1996). https://doi.org/10.1007/BF01716075

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01716075

Keywords

Navigation